TNFRSF17 and plasma cell myeloma: BCMA is detectable in malignant PCs throughout the duration of the disease, with progressive increased expression from monoclonal gammopathy of uncertain significance (MGUS) to smoldering myeloma to active MM, with the highest levels correlated to the worst prognosis (137).